Stockreport

BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Announces BNT162 vaccine program for the prevention of COVID-19 infectionAnticipates start of clinical testing for vaccine in late April 2020 Plans to assemble a global [Read more]